About
Ascentage Pharma Grp International (HK:6855) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
Apr 20 2026
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
Mar 18 2026
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
Mar 11 2026
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
Feb 23 2026
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
Translate